It is worth noting that we found that the levels of CD4+ PD1+ and CD8+ PD1+ in newly diagnosed ALL patients with BCR-ABL positive were higher than those in the negative group, but there was no significant difference. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.